Long term molecular epidemiology of methicillin-susceptible staphylococcus aureus bacteremia isolates in Sweden

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Rasmussen, Gunlög ^a,b   Monecke, Stefan ^c,d   Brus, Ole ^a   Ehricht, Ralf ^c   Söderquist, Bo ^a,e  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c Alere Technologies GmbH   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e Örebro University   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CHLORAMPHENICOL; FUSIDIC ACID; GLYCYLCYCLINE DERIVATIVE; LINCOSAMIDE; MACROLIDE; METICILLIN; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; PSEUDOMONIC ACID; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLAZ GENE; BLOOD CULTURE; CHILD; CLONAL VARIATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; NEWBORN; NONHUMAN; POPULATION GENETIC STRUCTURE; PRESCRIPTION; PREVALENCE; RETROSPECTIVE STUDY; STAPHYLOCOCCAL BACTEREMIA; SWEDEN; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; MOLECULAR TYPING; PATHOGENICITY; PRESCHOOL CHILD; STAPHYLOCOCCAL INFECTIONS; VERY ELDERLY;

STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; SWEDEN;

EID: 84917739022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114276     Document Type: Article

References (32)

1. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, et al. (2006) Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Critical Care Medicine 34: 2588-2595.
2. Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, et al. (2004) Severe bloodstream infections: A population-based assessment. Crit Care Med 32: 992-997.
3. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
4. Ferry T, Perpoint T, Vandenesch F, Etienne J (2005) Virulence determinants in Staphylococcus aureus and their involvement in clinical syndromes. Curr Infect Dis Rep 7: 420-428.
5. Lyytikainen O, Ruotsalainen E, Jarvinen A, Valtonen V, Ruutu P (2005) Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001. Eur J Clin Microbiol Infect Dis 24: 399-404.
6. Benfield T, Espersen F, Frimodt-Moller N, Jensen AG, Larsen AR, et al. (2007) Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 13: 257-263.
7. El Atrouni WI, Knoll BM, Lahr BD, Eckel-Passow JE, Sia IG, et al. (2009) Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: A population-based study. Clinical Infectious Diseases 49: e130-138.
8. Laupland KB, Lyytikainen O, Sogaard M, Kennedy KJ, Knudsen JD, et al. (2013) The changing epidemiology of Staphylococcus aureus bloodstream infection: A multinational population-based surveillance study. Clin Microbiol Infect 19: 465-471.
9. Wyllie DH, Crook DW, Peto TE (2006) Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. Bmj 333: 281.
10. Rasmussen G, Monecke S, Ehricht R, Soderquist B (2013) Prevalence of Clonal Complexes and Virulence Genes among Commensal and Invasive Staphylococcus aureus Isolates in Sweden. PLoS One 8: e77477.
11. Aamot HV, Blomfeldt A, Eskesen AN (2012) Genotyping of 353 Staphylococcus aureus bloodstream isolates collected between 2004 and 2009 at a Norwegian university hospital and potential associations with clinical parameters. J Clin Microbiol 50: 3111-3114.
12. Tavares A, Faria NA, de Lencastre H, Miragaia M (2014) Population structure of methicillin-susceptible Staphylococcus aureus (MSSA) in Portugal over a 19-year period (1992-2011). Eur J Clin Microbiol Infect Dis 33: 423-432.
13. Miko BA, Hafer CA, Lee CJ, Sullivan SB, Hackel MA, et al. (2013) Molecular characterization of methicillin-susceptible Staphylococcus aureus clinical isolates in the United States, 2004 to 2010. Journal of Clinical Microbiology 51: 874-879.
14. Monecke S, Slickers P, Ehricht R (2008) Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol 53: 237-251.
15. Monecke S, Coombs G, Shore AC, Coleman DC, Akpaka P, et al. (2011) A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 6: e17936.
16. Monecke S, Jatzwauk L, Weber S, Slickers P, Ehricht R (2008) DNA microarray-based genotyping of methicillin-resistant Staphylococcus aureus strains from Eastern Saxony. Clin Microbiol Infect 14: 534- 545.
17. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38: 1008-1015.
18. Grundmann H, Aanensen DM, van den Wijngaard CC, Spratt BG, Harmsen D, et al. (2010) Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: A molecularepidemiological analysis. PLoS Med 7: e1000215.
19. Goering RV, Shawar RM, Scangarella NE, O'Hara FP, Amrine-Madsen H, et al. (2008) Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. Journal of Clinical Microbiology 46: 2842-2847.
20. Fenner L, Widmer AF, Frei R (2008) Molecular epidemiology of invasive methicillin-susceptible Staphylococcus aureus strains circulating at a Swiss University Hospital. European Journal of Clinical Microbiology and Infectious Diseases 27: 623-626.
21. Fowler VG Jr., Nelson CL, McIntyre LM, Kreiswirth BN, Monk A, et al. (2007) Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 196: 738-747.
22. Feil EJ, Cooper JE, Grundmann H, Robinson DA, Enright MC, et al. (2003) How clonal is Staphylococcus aureus? J Bacteriol 185: 3307-3316.
23. Blomfeldt A, Aamot HV, Eskesen AN, Muller F, Monecke S (2013) Molecular Characterization of Methicillin-Sensitive Staphylococcus aureus Isolates from Bacteremic Patients in a Norwegian University Hospital. J Clin Microbiol 51: 345-347.
24. Melles DC, Gorkink RF, Boelens HA, Snijders SV, Peeters JK, et al. (2004) Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest 114: 1732-1740.
25. Larsson AK, Gustafsson E, Johansson PJ, Odenholt I, Petersson AC, et al. (2014) Epidemiology of MRSA in southern Sweden: strong relation to foreign country of origin, health care abroad and foreign travel. Eur J Clin Microbiol Infect Dis 33: 61-68.
26. Nulens E, Stobberingh EE, van Dessel H, Sebastian S, van Tiel FH, et al. (2008) Molecular characterization of Staphylococcus aureus bloodstream isolates collected in a Dutch University Hospital between 1999 and 2006. J Clin Microbiol 46: 2438-2441.
27. Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT (1999) In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother 43: 738-744.
28. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, et al. (2002) Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70: 631-641.
29. Watts A, Ke D, Wang Q, Pillay A, Nicholson-Weller A, et al. (2005) Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence. Infect Immun 73: 3502- 3511.
30. Otsuka T, Saito K, Dohmae S, Takano T, Higuchi W, et al. (2006) Key adhesin gene in communityacquired methicillin-resistant Staphylococcus aureus. Biochem Biophys Res Commun 346: 1234-1244.
31. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, et al. (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359: 753-759.
32. Badiou C, Dumitrescu O, Croze M, Gillet Y, Dohin B, et al. (2008) Panton-Valentine leukocidin is expressed at toxic levels in human skin abscesses. Clin Microbiol Infect 14: 1180-1183.